Company press releases

Released	Company	Title	Industry	Topic
23 Mar 2026 23:25 CET	GALAPAGOS	Galapagos and Gilead in Advanced Discussions to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases	20103010 Biotechnology	Other subject
23 Mar 2026 23:25 CET	GALAPAGOS	Galapagos en Gilead in vergevorderde gesprekken over samenwerking om een first-in-class T-cel-engagerprogramma voor auto-immuunziekten verder te ontwikkelen	20103010 Biotechnology	Other subject
17 Mar 2026 22:01 CET	GALAPAGOS	Galapagos Receives Transparency Notification from Bank of America	20103010 Biotechnology	Other subject
17 Mar 2026 22:01 CET	GALAPAGOS	Galapagos ontvangt transparantieverklaring van Bank of America	20103010 Biotechnology	Other subject
10 Mar 2026 22:01 CET	GALAPAGOS	Galapagos Receives Transparency Notifications from Bank of America	20103010 Biotechnology	Other subject
10 Mar 2026 22:01 CET	GALAPAGOS	Galapagos ontvangt transparantieverklaringen van Bank of America	20103010 Biotechnology	Other subject
06 Mar 2026 22:01 CET	GALAPAGOS	Galapagos Creates New Subscription Right Plan	20103010 Biotechnology	Other subject
06 Mar 2026 22:01 CET	GALAPAGOS	Galapagos creëert nieuw inschrijvingsrechtenplan	20103010 Biotechnology	Other subject
05 Mar 2026 22:01 CET	GALAPAGOS	Galapagos Appoints Tania Philipp as Chief Human Resources Officer	20103010 Biotechnology	Other subject
05 Mar 2026 22:01 CET	GALAPAGOS	Galapagos benoemt Tania Philipp tot Chief Human Resources Officer	20103010 Biotechnology	Other subject
04 Mar 2026 22:01 CET	GALAPAGOS	Galapagos Receives Transparency Notifications from Bank of America	20103010 Biotechnology	Other subject
04 Mar 2026 22:01 CET	GALAPAGOS	Galapagos ontvangt transparantieverklaringen van Bank of America	20103010 Biotechnology	Other subject
23 Feb 2026 22:01 CET	GALAPAGOS	Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update	20103010 Biotechnology	Other subject
23 Feb 2026 22:01 CET	GALAPAGOS	Galapagos rapporteert resultaten over het gehele jaar 2025 en geeft een business update over het vierde kwartaal	20103010 Biotechnology	Other subject
19 Feb 2026 22:01 CET	GALAPAGOS	Galapagos Welcomes Dr. Paulo Fontoura to its Board of Directors	20103010 Biotechnology	Other subject
19 Feb 2026 22:01 CET	GALAPAGOS	Galapagos verwelkomt Dr. Paulo Fontoura in haar Raad van Bestuur	20103010 Biotechnology	Other subject
16 Feb 2026 22:01 CET	GALAPAGOS	Galapagos Receives Transparency Notification from Bank of America	20103010 Biotechnology	Other subject
16 Feb 2026 22:01 CET	GALAPAGOS	Galapagos ontvangt transparantieverklaring van Bank of America	20103010 Biotechnology	Other subject
10 Feb 2026 22:01 CET	GALAPAGOS	Galapagos Receives Transparency Notifications from Bank of America	20103010 Biotechnology	Other subject
10 Feb 2026 22:01 CET	GALAPAGOS	Galapagos ontvangt transparantieverklaringen van Bank of America	20103010 Biotechnology	Other subject
05 Jan 2026 22:01 CET	GALAPAGOS	Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities	20103010 Biotechnology	Other subject
05 Jan 2026 22:01 CET	GALAPAGOS	Galapagos kondigt besluit van de Raad van Bestuur aan om de afbouw van de celtherapieactiviteiten te starten	20103010 Biotechnology	Other subject
18 Dec 2025 22:01 CET	GALAPAGOS	Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus	20103010 Biotechnology	Other subject
18 Dec 2025 22:01 CET	GALAPAGOS	Galapagos maakt topline resultaten bekend van twee fase 3-enabling studies met selectieve TYK2-remmer GLPG3667 bij dermatomyositis en systemische lupus erythematodes	20103010 Biotechnology	Other subject
08 Dec 2025 07:30 CET	GALAPAGOS	Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025	20103010 Biotechnology	Other subject
08 Dec 2025 07:30 CET	GALAPAGOS	Galapagos presenteerde nieuwe ATALANTA-1 celtherapiedata in MCL op ASH 2025	20103010 Biotechnology	Other subject
26 Nov 2025 07:30 CET	GALAPAGOS	Galapagos Receives Transparency Notifications from Bank of America	20103010 Biotechnology	Other subject
26 Nov 2025 07:30 CET	GALAPAGOS	Galapagos ontvangt transparantieverklaringen van Bank of America	20103010 Biotechnology	Other subject
05 Nov 2025 22:01 CET	GALAPAGOS	Galapagos Reports Nine Months 2025 Financial Results and Provides Business Update	20103010 Biotechnology	Other subject
05 Nov 2025 22:01 CET	GALAPAGOS	Galapagos rapporteert financiële resultaten over de eerste negen maanden van 2025 en geeft bedrijfsupdate	20103010 Biotechnology	Other subject
03 Nov 2025 22:01 CET	GALAPAGOS	Galapagos to Present New Data from Cell Therapy Program at ASH 2025	20103010 Biotechnology	Other subject
03 Nov 2025 22:01 CET	GALAPAGOS	Galapagos zal nieuwe gegevens presenteren over celtherapieprogramma tijdens ASH 2025	20103010 Biotechnology	Other subject
30 Oct 2025 21:01 CET	GALAPAGOS	Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development	20103010 Biotechnology	Other subject
30 Oct 2025 21:01 CET	GALAPAGOS	Galapagos kondigt wijzigingen aan in de Raad van Bestuur om de strategische focus op business development te versnellen	20103010 Biotechnology	Other subject
23 Oct 2025 22:01 CEST	GALAPAGOS	Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors	20103010 Biotechnology	Other subject
23 Oct 2025 22:01 CEST	GALAPAGOS	Galapagos presenteert in vitro-gegevens tijdens ACR Convergence 2025 die wijzen op differentiatie van GLPG3667 ten opzichte van andere TYK2-remmers	20103010 Biotechnology	Other subject
21 Oct 2025 07:30 CEST	GALAPAGOS	Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation	20103010 Biotechnology	Other subject
21 Oct 2025 07:30 CEST	GALAPAGOS	Galapagos kondigt intentie aan om celtherapieactiviteiten af te bouwen als onderdeel van de voortdurende transformatie van het bedrijf	20103010 Biotechnology	Other subject
16 Oct 2025 22:01 CEST	GALAPAGOS	Galapagos Announces Appointment of Fred Blakeslee as General Counsel	20103010 Biotechnology	Other subject
16 Oct 2025 22:01 CEST	GALAPAGOS	Galapagos kondigt benoeming aan van Fred Blakeslee als General Counsel	20103010 Biotechnology	Other subject
01 Oct 2025 22:01 CEST	GALAPAGOS	Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business	20103010 Biotechnology	Other subject
01 Oct 2025 22:01 CEST	GALAPAGOS	Galapagos geeft update over strategische alternatieven voor haar celtherapieactiviteiten	20103010 Biotechnology	Other subject
07 Aug 2025 22:01 CEST	GALAPAGOS	Galapagos Creates New Subscription Right Plan	20103010 Biotechnology	Other subject
07 Aug 2025 22:01 CEST	GALAPAGOS	Galapagos creëert nieuw inschrijvingsrechtenplan	20103010 Biotechnology	Other subject
06 Aug 2025 07:30 CEST	GALAPAGOS	Galapagos NV kondigt aan dat GLPG5101 de status van Regenerative Medicine Advanced Therapy (RMAT) van de FDA krijgt voor de behandeling van recidief/refractair mantelcellymfoom	20103010 Biotechnology	Other subject
06 Aug 2025 07:30 CEST	GALAPAGOS	Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma	20103010 Biotechnology	Other subject
23 Jul 2025 22:03 CEST	GALAPAGOS	Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation	20103010 Biotechnology	Other subject
23 Jul 2025 22:03 CEST	GALAPAGOS	Galapagos versterkt managementteam met ervaren life sciences leidinggevenden om bedrijfstransformatie te versnellen	20103010 Biotechnology	Other subject
23 Jul 2025 22:02 CEST	GALAPAGOS	Galapagos Welcomes Seasoned Pharmaceutical Executives Dawn Svoronos and Jane Griffiths to Its Board of Directors	20103010 Biotechnology	Other subject
23 Jul 2025 22:02 CEST	GALAPAGOS	Galapagos verwelkomt ervaren farmaceutische leidinggevenden Dawn Svoronos en Jane Griffiths in haar Raad van Bestuur	20103010 Biotechnology	Other subject

Topic

Provider

Ημερομηνία